🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label, phase III study evaluating the efficacy and safety o...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-05-06
Trial ID
NCT05841381
Treatments Being Tested
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
This study aims to evaluate the efficacy and safety of pyrotinib in combina...
Status
Active Not Recruiting
Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Start Date
2020-05-30
Trial ID
NCT04398914
Treatments Being Tested
Patients with Stage II-III HER2-positive breast cancer will receive three c...
Status
Recruiting
Location
Shanghai Jiaotong University School of Medicine affiliated Ruijin Hospital
Start Date
2026-02-02
Trial ID
NCT07393425
This prospective, response-guided phase II study investigates individualize...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2025-12-25
Trial ID
NCT07340398
Treatments Being Tested
This study was designed to evaluate the efficacy and safety of pyrotinib co...
Status
Unknown
Location
West China Hospital, Sichuan University
Start Date
2019-11
Trial ID
NCT04152057
Treatments Being Tested
Targeting human epidermal factor receptor 2 (HER2) therapy have shown the a...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2020-02-01
Trial ID
NCT04960943
Treatments Being Tested
This study is a prospective, single arm, multi-center clinical trial. The p...
Status
Recruiting
Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Start Date
2024-12-03
Trial ID
NCT06832904
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of pyrotinib...
Status
Unknown
Location
Zhiyong Yu
Start Date
2021-01-01
Trial ID
NCT04639271
Treatments Being Tested
Breast cancer is kind of highly heterogeneous tumor. The patients with the ...
Status
Unknown
Location
JiangSu Province Hospital/ The First Affiliated Hospital of Nanjing Medical University
Start Date
2022-11-29
Trial ID
NCT05659056
Treatments Being Tested